CD4 regulatory T cells are thought to inhibit T cell activation in autoimmune and virus-related liver diseases, indicating a correlation between elevated CD4 regulatory T cells and reduced CD8 T cells in WD patients (Zhang et al., 2016). This evidence concerns the gene CD8A and Wilson disease.